Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Kidney International

DOI: 10.1038/ki.2012.63 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 6 stored of 583

Pivotal clinical trials in C3 glomerulopathy: answers and remaining uncertainties
2026 Nephrology Dialysis Transplantation article Immunology and Microbiology Complement system in diseases Open access

0

citations
Artificial Intelligence in Kidney Transplant Pathology: Current Evidence, Limitations, and Relevance to the Banff Framework
2026 Kidney International Reports article Computer Science AI in cancer detection Open access

0

citations
Complement-Mediated Kidney Diseases: Role of Alternative Pathway in Glomerular Inflammation
2025 Kidney International Reports article Immunology and Microbiology Complement system in diseases Open access

3

citations
Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
2024 Kidney International Reports article Medicine Renal Diseases and Glomerulopathies Open access

7

citations
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
2022 Clinical Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent

52

citations
Management and treatment of glomerular diseases (part 2): Conclusions From A Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference
2021 Nephrology (Saint-Petersburg) article Medicine Renal Diseases and Glomerulopathies Open access

4

citations

6 results

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

Authors 0

Cited by 6 stored of 583

References 0